Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...

Biogen Inc. (NASDAQ:BIIB) is one of the top cheap pharmaceutical stocks to buy now. BofA lowered the firm’s price target on Biogen Inc. (NASDAQ:BIIB) to $142 from $143 on August 1, keeping a Neutral ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

May 05, 2025 — 10:20 am EDT Written by Quiver ForecastTracker for Quiver Quantitative -> ...

If an investor was to purchase shares of BIIB stock at the current price level of $261.97/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Our analysis of options history for Biogen (NASDAQ: BIIB) revealed 12 unusual trades. Delving into the details, we found 25% of traders were bullish, while 66% showed bearish tendencies.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biogen Inc (Symbol: BIIB), where a total of 11,859 contracts have traded so far ...

In early trading on Thursday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.3%. Year to date, Biogen registers a 10.3% gain.